Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
Read time: 1 mins
Last updated:15th Apr 2012
The purpose of this study is to assess the capability of the dPCR technique to predict the absence of disease relapses after imatinib discontinuation in CML patients with negative Q-RT-PCR results for longer than 18 months.
|Study start date||2012-04-15|